December 5, 2021

Infectious Disease Market Size to Grow by USD 62.83 bn | Increasing Prevalence of Infectious Diseases to Boost Growth | Technavio

NEW YORK, Nov. 23, 2021 /PRNewswire/ — The infectious disease market size is expected to grow by USD 62.83 bn…

NEW YORK, Nov. 23, 2021 /PRNewswire/ — The infectious disease market size is expected to grow by USD 62.83 bn from 2020 to 2025, decelerating at a CAGR of 10.19%, according to Technavio. The report offers an up-to-date analysis as well as exact growth variance and the Y-O-Y growth rate 

Request a Free Sample Report to explore growth opportunities in the infectious disease market

The infectious disease market is fragmented, and the degree of fragmentation will decelerate during the forecast period. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments while maintaining their positions in the slow-growing segments.

The infectious disease market report covers the following areas:

Infectious Disease Market 2021-2025: Segmentation

  • Product
    • Drugs
    • Vaccines
  • Geography
    • North America
    • Europe
    • Asia
    • ROW

To learn more about the contribution of various market segments, Download a Free Sample

Infectious Disease Market 2021-2025: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources.

The increasing prevalence of infectious diseases, growing awareness of infectious diseases, and strong drug pipeline will offer immense growth opportunities. However, generic erosion, adverse effects of anti-infective drugs, and slowdown in the manufacturing industry will challenge the growth of the market participants.

Infectious Disease Market 2021-2025 : Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the infectious disease market, including AbbVie Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Inc., Merck and Co. Inc., Pfizer Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd. Backed with competitive intelligence and benchmarking, our research report on the infectious disease market is designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.

Subscribe to our “Lite Plan” billed annually at USD 3000 that enables you to download 3 reports/year and view 3 reports/month.

Infectious Disease Market 2021-2025: Regional Analysis

Technavio offers an up-to-date analysis of the geographical composition of the market as well as competitive intelligence and regional opportunities for vendors. According to our research, 40% of the market’s growth is expected to originate from North America during the forecast period. The US is the key country for the infectious diseases market in North America. The region has been recording a significant growth rate. Hence, it is expected to offer several growth opportunities to market vendors during the forecast period. The growing awareness of infectious diseases will facilitate the infectious disease market growth in North America during the forecast period.

Infectious Disease Market 2021-2025: Key Highlights

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will assist infectious disease market growth during the next five years
  • Estimation of the infectious disease market size and its contribution to the parent market
  • Predictions on upcoming trends and changes in consumer behavior
  • The growth of the infectious disease market
  • Analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of infectious disease market vendors

Related Reports:

  • Covid-19 Vaccination Market: The Covid-19 vaccination market has been segmented by application (mRNA and others) and geography (North America, Asia, Europe, and ROW). Download Free Sample Report
  • Glioblastoma Multiforme Treatment Market: The glioblastoma multiforme treatment market has been segmented by end-user (hospitals, clinics, and ambulatory surgical centers) and geography (North America, Europe, Asia, and ROW). Download Free Sample Report

Infectious Disease Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Decelerate at a CAGR of 10.19%

Market growth 2021-2025

USD 62.83 billion

Market structure

Fragmented

YoY growth (%)

16.04

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 40%

Key consumer countries

US, Germany, UK, China, and Japan

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

AbbVie Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Inc., Merck and Co. Inc., Pfizer Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd.

Market Dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: media@technavio.com

Website: www.technavio.com/

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/infectious-disease-market-size-to-grow-by-usd-62-83-bn–increasing-prevalence-of-infectious-diseases-to-boost-growth–technavio-301429926.html

SOURCE Technavio